GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pixium Vision SA (OTCPK:PXMVD) » Definitions » ROCE %

Pixium Vision (Pixium Vision) ROCE % : -315.92% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Pixium Vision ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pixium Vision's annualized ROCE % for the quarter that ended in Jun. 2023 was -315.92%.


Pixium Vision ROCE % Historical Data

The historical data trend for Pixium Vision's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pixium Vision ROCE % Chart

Pixium Vision Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.74 -58.51 -76.25 -77.78 -109.67

Pixium Vision Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -86.48 -80.05 -114.80 -132.44 -315.92

Pixium Vision ROCE % Calculation

Pixium Vision's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-10.282/( ( (22.18 - 7.324) + (13.109 - 9.215) )/ 2 )
=-10.282/( (14.856+3.894)/ 2 )
=-10.282/9.375
=-109.67 %

Pixium Vision's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=-12.302/( ( (13.109 - 9.215) + (0 - 0) )/ 1 )
=-12.302/( ( 3.894 + 0 )/ 1 )
=-12.302/3.894
=-315.92 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pixium Vision  (OTCPK:PXMVD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Pixium Vision ROCE % Related Terms

Thank you for viewing the detailed overview of Pixium Vision's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pixium Vision (Pixium Vision) Business Description

Traded in Other Exchanges
Address
74 rue du Faubourg Saint Antoine, Paris, FRA, 75012
Pixium Vision SA is engaged in the business of developing implantable medical devices to treat blindness resulting from the degeneration of retinal photoreceptor cells.

Pixium Vision (Pixium Vision) Headlines

No Headlines